The Aspergillus fumigatus toxin fumagillin

suppresses the immune response of Galleria

mellonella larvae by inhibiting the action of

haemocytes by Fallon, John P. et al.
The Aspergillus fumigatus toxin fumagillin
suppresses the immune response of Galleria
mellonella larvae by inhibiting the action of
haemocytes




Received 14 July 2010
Revised 15 November 2010
Accepted 21 February 2011
1Medical Mycology Unit, Department of Biology, National Institute for Cellular Biotechnology,
National University of Ireland Maynooth, Co. Kildare, Ireland
2Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland,
Beaumont Hospital, Dublin 9, Ireland
Larvae of Galleria mellonella are widely used to evaluate microbial virulence and to assess the in
vivo efficacy of antimicrobial agents. The aim of this work was to examine the ability of an
Aspergillus fumigatus toxin, fumagillin, to suppress the immune response of larvae. Administration
of fumagillin to larvae increased their susceptibility to subsequent infection with A. fumigatus
conidia (P50.0052). It was demonstrated that a dose of 2 mg fumagillin ml”1 reduced the ability
of insect immune cells (haemocytes) to kill opsonized cells of Candida albicans (P50.039) and to
phagocytose A. fumigatus conidia (P50.016). Fumagillin reduced the oxygen uptake of
haemocytes and decreased the translocation of a p47 protein which is homologous to p47phox, a
protein essential for the formation of a functional NADPH oxidase complex required for superoxide
production. In addition, toxin-treated haemocytes showed reduced levels of degranulation as
measured by the release of a protein showing reactivity to an anti-myeloperoxidase antibody
(P,0.049) that was subsequently identified by liquid chromatography-MS analysis as
prophenoloxidase. This work demonstrates that fumagillin suppresses the immune response of
G. mellonella larvae by inhibiting the action of haemocytes and thus renders the larvae susceptible
to infection. During growth of the fungus in the larvae, this toxin, along with others, may facilitate
growth by suppressing the cellular immune response.
INTRODUCTION
The fungus Aspergillus fumigatus is widely distributed in
the environment and is capable of inducing disease in those
with pre-existing pulmonary malfunction (e.g. asthma,
cystic fibrosis), disease (e.g. tuberculosis, lung cancer) or
undergoing immunosuppressive therapy prior to organ
transplantation (Vonberg & Gastmeier, 2006). Colonies of
A. fumigatus produce conidia, and due to their small size
(2–4 mm) these are inhaled deep into the alveoli of the lung
and can initiate infection if the immune system is deficient
or weakened. Three forms of aspergillosis are recognized
clinically: saprophytic, allergic and invasive. Invasive
aspergillosis (IA) is the most serious form of disease as it
involves the invasion of viable tissue and may produce a
mortality rate of 80–95% (Brakhage & Langfelder, 2002;
Rementeria et al., 2005). IA has emerged as an important
disease in recent decades due to the use of aggressive
immunosuppressive therapy that causes prolonged neu-
tropenia in the treatment of cancer and leukaemia.
Vandewoude et al. (2004) have estimated that mortality
attributable to IA is 19% in intensive care units.
Furthermore the incidence of IA in solid organ transplant
patients may be up to 15%, with mortality ranging from 65
to 92% (Singh et al., 2009).
A. fumigatus produces a range of hydrolytic enzymes and
mycotoxins, such as gliotoxin, helvolic acid and fumagillin,
which may facilitate its growth and persistence in the lung
(Tekaia & Latge´, 2005). Gliotoxin possesses a number of
powerful bioactivities, including inhibition of activation of
the NADPH oxidase of human neutrophils (Tsunawaki
et al., 2004). It has been detected in tissue samples from
animals (Richard & DeBey, 1995; Richard et al., 1996) and
humans (Lewis et al., 2005), where it may facilitate fungal
persistence and colonization of tissue. In addition,
gliotoxin has been implicated in the destruction of lung
parenchyma in IA (Sutton et al., 1996) and the penetration
of blood vessels in angio-invasive aspergillosis (Fraser,
1993).
Abbreviations: IA, invasive aspergillosis; LC-MS, liquid chromatography-
MS; MPO, myeloperoxidase; PMA, phorbol-12-myristate-13-acetate;
PPO, prophenoloxidase; ROS, reactive oxygen species.
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Fumagillin (C26H34O7, 458.6 Da) is also produced by
A. fumigatus during hyphal development (Mitchell et al.,
1997). The toxin has well-established amoebicidal prop-
erties (McCowen et al., 1951) and has been identified as an
inhibitor of angiogenesis through a covalent interaction
with methionine aminopeptidase-2 (MetAP-2) (Ingber
et al., 1990). Fumagillin can retard the ciliary beat
frequency of pulmonary epithelial cells and thus may
facilitate the continued persistence of A. fumigatus conidia
in the lung (Amitani et al., 1995). Fumagillin inhibits the
growth of colorectal cancer cells and retards metastasis in
mice; however, the molecular mechanism of the various
activities of fumagillin is ill defined (Hou et al., 2009).
The insect immune response and the innate immune
response of mammals demonstrate many structural and
functional similarities, and as a consequence insects have
been utilized to evaluate the virulence of a variety of
microbial pathogens and to model the innate immune
response without the requirement for mammals (Kavanagh
& Reeves, 2004; Fuchs & Mylonakis, 2006; Lionakis &
Kontoyiannis, 2005). Insect haemocytes and human neu-
trophils demonstrate a number of similarities in terms of
their ability to phagocytose and kill pathogens. We
previously demonstrated that reactive oxygen species
(ROS) production in haemocytes of Galleria mellonella is
mediated by an NADPH oxidase complex that contains
proteins homologous to the p40phox, p47phox, p67phox and
gp91phox of human neutrophils (Bergin et al., 2005). In
addition, the homologous cytosolic proteins (p40, p47 and
p67) translocate from the cytosol to the membrane fraction
in stimulated haemocytes (Renwick et al., 2007). Insects have
been employed to assess the virulence of bacteria (Mansfield
et al., 2003), fungi (Cotter et al., 2000) and parasites
(Boulanger et al., 2001), and positive correlations with results
from murine studies have been demonstrated for Candida
albicans (Brennan et al., 2002) and Pseudomonas aeruginosa
(Jander et al., 2000).G. mellonella larvae have been employed
to measure the virulence of clinical isolates of A. fumigatus
(Reeves et al., 2004; Jackson et al., 2009).
While insects are now widely used to measure the virulence of
fungal pathogens (Mylonakis et al., 2005; Fuchs & Mylonakis,
2006) and A. fumigatus isolates in particular (Reeves et al.,
2004; Lionakis et al., 2005; Lionakis & Kontoyiannis, 2005),
the ability of A. fumigatus to grow within the haemocoel of
G. mellonella larvae and the insect immune response to the
fungus are ill defined. The aim of the work presented here was
to establish whether fumagillin alters the cellular immune
response of larvae and so facilitates the growth ofA. fumigatus.
Characterizing the interaction of this toxin with the insect
immune response could give insights into how the toxin
interacts with the immune system of mammals and establish
its role in facilitating fungal growth in vivo.
METHODS
Chemicals and reagents. All chemicals were of the highest purity
and were purchased from Sigma-Aldrich, unless otherwise stated.
Larval inoculation. Sixth instar larvae of the Greater Wax Moth,
G. mellonella (The Mealworm Company Ltd), were stored in the dark
at 15 uC. Larvae (0.2–0.4 g) were selected at random and all
experiments were performed independently on three occasions.
Larvae were inoculated with 16107 conidia in 20 ml through the
last left pro-leg into the haemocoel with a Myjector U-100 insulin
syringe (Terumo Europe). Larvae were inoculated with 20 ml of 0.1, 1
or 2 mg fumagillin ml21. Fumagillin was dissolved in methanol and
serially diluted so that the 2 mg fumagillin ml21 dose was in 10%, v/v,
methanol. A solvent (10%, v/v, methanol) control was used in all
experiments.
Fungal cultures. A. fumigatus ATCC 26933 was grown on malt
extract agar plates at 37 uC for 7 days, and conidia were harvested by
rinsing with PBS supplemented with 0.01% (v/v) Tween-80.
Following centrifugation at 500 g for 5 min, conidia were washed
in sterile PBS and enumerated using a haemocytometer. C. albicans
MEN was maintained on YEPD agar and grown for approximately
24 h in YEPD broth [2% (w/v) glucose, 2% (w/v) bactopeptone
(Difco Laboratories), 1% (w/v) yeast extract (Oxoid)] to the
stationary phase. C. albicans cells were washed twice in sterile PBS
and enumerated by haemocytometry.
Haemocyte isolation. Larvae were bled through the anterior region,
and the resulting haemolymph was collected in sterile insect
physiological saline (IPS; 150 mM NaCl, 5 mM KCl, 100 mM Tris/
HCl, 10 mM EDTA, 30 mM sodium citrate, pH 6.9). Following
haemolymph collection, haemocytes were collected by centrifugation
at 500 g for 5 min and subsequently washed twice in IPS to remove
excess haemolymph protein. Cells were collected by centrifugation
and resuspended in PBS supplemented with 5 mM glucose. The
concentration of cells was determined by haemocytometry, and
cellular viability was assessed using the Trypan Blue exclusion assay.
In vitro phagocytosis and killing of pathogenic targets by
haemocytes. Isolated haemocytes (56106 ml21) were incubated in
the presence of 2 mg fumagillin ml21 for 25 min at 37 uC. A.
fumigatus conidia were opsonized using cell-free haemolymph for
40 min at 37 uC. Phagocytosis was measured by incubating pre-
treated haemocytes (56106) with opsonized A. fumigatus conidia
(16107) in a final volume of 1 ml in a stirred thermally controlled
chamber at 37 uC. An aliquot was removed immediately after the
addition of conidia to the cells (t50), and after a further 30, 60 and
120 min of incubation. Three hundred haemocytes were examined
and the number of cells containing phagocytosed conidia was
ascertained by microscopy. The dark-green colour of A. fumigatus
conidia facilitated the visualization of phagocytosed conidia. The
mean±SEM was calculated.
Assays to determine the effect of 2 mg fumagillin ml21 on the
microbicidal activity of haemocytes (56106) employed haemolymph-
opsonized C. albicans cells at a ratio of 2.56106 to 56106
haemocytes in a final volume of 1 ml. Aliquots were removed at
t50, 20, 40 and 60 min and serially diluted in ice-cold minimal
essential medium (MEM) to quench phagocytosis, prior to plating on
YEPD plates to ascertain viability. The percentage reduction in
pathogen viability was calculated in relation to the initial viability of
the C. albicans cells. Cells of C. albicans were chosen for use in the
microbicidal assay as the kinetics of their killing by haemocytes is well
characterized (Bergin et al., 2005).
Measurement of oxygen consumption. Oxygen consumption was
measured in a thermostatically controlled (37 uC) chamber attached
to a Clarke-type oxygen electrode. The rate of oxygen consumption
was calculated based on the fact that the oxygen content of PBS at
37 uC is 230 nmol ml21 (Segal & Coade, 1978). Haemocytes were
pre-treated with 2 mg fumagillin ml21 at 37 uC for 25 min, and
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56107 cells were placed in a thermally controlled stirred chamber and
stimulated with phorbol-12-myristate-13-acetate (PMA; 1 mg ml21).
Subcellular fractionation of haemocytes. Haemocytes were
fractionated using the method described by Renwick et al. (2007).
In brief, haemocytes (16108 ml21) were incubated in the presence of
2 mg fumagillin ml21 for 25 min, harvested, washed and exposed to
1 mg PMA ml21 for 6 min. Following treatment, cells were harvested
by centrifugation and resuspended in 500 ml break buffer (10 mM
KCl, 3 mM NaCl, 4 mM MgCl2, 10 mM PIPES, pH 7.2) containing
protease inhibitors [10 mg ml21 leupeptin, pepstatin A, aprotinin and
N-a-p-tosyl-L-lysine chloromethylketone hydrochloride (TLCK)],
sonicated (Bandelin Sonopuls) three times for 5 s at 20% power,
and centrifuged at 200 g for 10 min at 4 uC. The post-nuclear
supernatant (PNS) was centrifuged at 100 000 g for 1 h at 4 uC in a
Beckman SW 60 Ti rotor. The membrane pellet was solubilized in
break buffer supplemented with 36 mM CHAPS by mixing for 1 h.
The membrane fraction was sonicated for five 1 min intervals with
cooling on ice in between. The solubilized fraction was centrifuged at
7000 g to remove any membrane debris. Bradford assay reagent (Bio-
Rad Laboratories) was used to assay the amount of protein in each
fraction, using BSA as standard.
Assessment of degranulation in haemocytes. Haemocytes
(56107 ml21) were exposed to 2 mg fumagillin ml21 for 25 min at
37 uC, and resuspended in PBS containing 5 mM glucose and
protease inhibitors as described above. Following PMA (1 mg ml21)
stimulation in a stirred chamber, an aliquot was removed at 6 min
[previously established to be optimal for detecting degranulation
(data not shown)]. Cells were removed by centrifugation (800 g). The
protein content of the supernatant was precipitated and prepared for
electrophoresis and immunoblotting.
Electrophoresis and immunoblotting. Samples were separated by
SDS-PAGE (12.5% acrylamide), and protein profiles were visualized
by colloidal Coomassie staining. For Western blotting, the protein
was transferred to a nitrocellulose membrane using wet blotting for
70 min at 100 V. Rabbit polyclonal antisera raised against human
p47phox were used at a dilution of 1 : 3000 overnight at 4 uC. This
anti-p47phox antibody had previously been employed to identify p47
in insect haemocytes (Bergin et al., 2005; Renwick et al., 2007).
Myeloperoxidase (MPO) antiserum raised in rabbit (Genway) was
used at a dilution of 1 : 650 overnight at 4 uC. Secondary antibody
employed horseradish peroxidase-linked rabbit antisera at a dilution
of 1 : 2000. Enhanced chemiluminescence (Pierce Biotechnology) was
employed to develop reactive protein bands for MPO-like reactivity.
3,39-Diaminobenzidine (DAB) staining was utilized for p47phox-like
staining and quantified by densitometry using ImageJ software. The
data from four blots were used to determine the statistical significance
between treatments.
Liquid chromatography-MS (LC-MS) analysis. In-gel digestion of
the immunoreactive band was performed according to the method of
Shevchenko et al. (2006). Briefly, the protein band corresponding to
the MPO reactive band was excised and washed for approximately
60 min in 150 ml 100 mM ammonium bicarbonate/acetonitrile (1 : 1,
v/v). Following removal of the wash buffer, gel pieces were incubated
in 500 ml acetonitrile until the gel pieces became white and shrank.
Following removal of acetonitrile, the excised bands were digested
overnight in 13 ng trypsin ml21. Peptides were extracted and vacuum-
dried prior to LC-MS analysis on an Agilent 6340 ion trap mass
spectrometer. The resulting data were analysed using the Mascot
search engine (http://www.matrixscience.com). The mass error
tolerance was 1 Da, allowing for a maximum of no more than two
missed cleavages. Verification of protein sequences was confirmed by
BLAST analysis of the protein sequence on the UniProt (http://www.
uniprot.org) and National Center for Biotechnology Information
(NCBI) (http://www.ncbi.nlm.nih.gov) websites.
Statistics. All values are the mean±SD of at least three independent
determinations. Experimental data were tested for statistical signifi-
cance at P,0.05 using a Student’s t test (Minitab 14 package). Larval
viability data (Fig. 1) were analysed using the log rank test.
RESULTS
Effect of fumagillin on susceptibility of
G. mellonella larvae to A. fumigatus infection
In order to evaluate the ability of fumagillin to alter the
immune response of G. mellonella, larvae were adminis-
tered the toxin and their response to infection with conidia
of A. fumigatus was monitored. The administration of
fumagillin had no adverse effect on the viability of larvae
over 72 h (data not shown). However, larvae administered
2 mg fumagillin ml21 for 4 h and subsequently infected
with 16107 A. fumigatus conidia in a 20 ml volume
demonstrated increased mortality compared with those
infected with A. fumigatus conidia without prior exposure
to the toxin (Fig. 1). At 72 h, 80±5.7% of larvae that had
received 2 mg fumagillin ml21 had died compared with
53.3±12.0% of those that had not received the toxin prior
to fungal inoculation (P50.0052). In contrast, administra-
tion of 0.1 or 1.0 mg fumagillin ml21 to larvae only resulted
in small alterations in the susceptibility of larvae to
Fig. 1. Effect of fumagillin on susceptibility of G. mellonella larvae
to A. fumigatus infection. Larvae were inoculated with different
concentrations of fumagillin (Fum) and were subsequently injected
with 1107 A. fumigatus conidia and incubated at 37 6C. Larval
viability was determined at 24, 48 and 72 h post fungal
inoculation. Larvae that were administered 2 mg fumagillin ml”1
prior to conidial inoculation showed a significant reduction in
viability compared with those which only received conidia (Solv
Ctrl+conidia) (P50.0052).
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infection (P¢0.7). Interestingly, we have previously
detected fumagillin concentrations of 3 mg (g larval
tissue)21 in insects infected with A. fumigatus for 24 h
(data not shown). As a result of this finding, subsequent
work concentrated on examining the ability of 2 mg
fumagillin ml21 to alter haemocyte function.
Fumagillin retards the killing and phagocytic
abilities of G. mellonella haemocytes
The insect immune response consists of cellular and
humoral components, and the cellular immune response
is mediated by immune cells called haemocytes, which can
phagocytose and kill invading pathogens (Morton et al.,
1987). Haemocytes (viability 95%) were extracted from G.
mellonella larvae and exposed to 2 mg fumagillin ml21 for
25 min. The viability of haemocytes after this incubation
period was 88.8±1.7%. Toxin-treated haemocytes were
mixed with opsonized cells of C. albicans in a ratio of 1 : 2,
and the ability of the haemocytes to kill the fungal cells was
assessed as described above. The results demonstrated that
haemocytes exposed to 2 mg fumagillin ml21 had a
significantly reduced ability to kill C. albicans compared
with solvent-treated or control haemocytes (P50.039 at
60 min; Fig. 2). For example, at 60 min, C. albicans cell
viability was 33.56±4.3% when fumagillin-treated hae-
mocytes were employed but 11.59±1.0% when the
solvent-treated haemocytes were employed in the assay
(P50.048).
The capacity of fumagillin to alter the phagocytic ability of
haemocytes was investigated and revealed that those
haemocytes that had been exposed to 2 mg fumagillin
ml21 for 25 min prior to mixing with A. fumigatus conidia
demonstrated reduced phagocytosis (Fig. 3). At 60 min,
43.2±3.8% of fumagillin-treated haemocytes had engulfed
a conidium, while 54.9±5.6% of solvent-treated haemo-
cytes had phagocytosed (P50.016).
Fumagillin reduces the oxygen uptake of
haemocytes and retards the cytosol–membrane
translocation of p47 protein
Once phagocytosis has been accomplished by a haemocyte,
the engulfed pathogen can be killed by the generation of
ROS and the release of proteolytic enzymes in the process
of degranulation. Oxygen uptake is essential for ROS
production and is mediated by an NADPH oxidase
complex which shows similarity to that in neutrophils
(Bergin et al., 2005). The oxygen consumption ability of
fumagillin-treated haemocytes was reduced significantly
(Fig. 4). After 10 min, the difference in oxygen consump-
tion between fumagillin-treated haemocytes and solvent-
treated haemocytes was significant at P50.003.
ROS production is mediated by an NADPH oxidase
complex that consists of membrane (gp91phox) and
cytosolic (p40phox, p47phox and p67phox) proteins in
neutrophils and of homologous proteins in haemocytes
Fig. 2. Fumagillin-treated haemocytes are less effective in killing C.
albicans cells. Haemocytes (5106) were incubated in the
presence of 2 mg fumagillin ml”1 (Fum) prior to incubation with
opsonized C. albicans (2.5106). Aliquots were removed at
regular intervals and diluted in ice-cold MEM to quench
phagocytosis, and a 100 ml volume was spread on a YEPD-
erythromycin agar plate. Significant reductions in cell-mediated
killing by toxin-treated haemocytes were observed compared with
the PBS control (PBS Ctrl) and solvent control (Solv Ctrl)
(P50.039).
Fig. 3. Phagocytosis ability of fumagillin-treated haemocytes.
Haemocytes (5106) were incubated in the presence of 2 mg
fumagillin ml”1 (Fum) and mixed with opsonized conidia. Aliquots
were removed at 0, 30, 60 and 120 min and examined by light
microscopy to ascertain the level of phagocytosis. Cells pre-
treated with fumagillin demonstrated a significant (P50.016)
reduction in phagocytosis compared with cells which were pre-
incubated in the PBS control (PBS Ctrl) or the solvent control
(Solv Ctrl) at 120 min.
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(Bergin et al., 2005). The cytosolic proteins translocate to
the membrane upon cellular activation and lead to the
formation of a functional NADPH oxidase (Renwick et al.,
2007). The ability of fumagillin to retard the translocation
of p47 was assessed by exposing cells to 2 mg fumagillin
ml21 and subsequently isolating cytosolic and membrane
fractions. These were resolved by 1D SDS-PAGE, blotted
and probed with an antibody that reacts with an insect p47
protein previously shown to be homologous to the p47phox
protein in the NADPH oxidase complex of neutrophils
(Bergin et al., 2005; Renwick et al., 2007). The results
revealed that cells exposed to fumagillin showed lower
levels of p47 in the membrane fraction than those in the
PMA-activated cells (P50.05) (Fig. 5). Immunoblot
analysis of haemocyte fractionation showed the presence
of p47 protein in the cytosolic fraction of unstimulated
cells, with a translocation of the protein to the membrane
fraction upon PMA stimulation (P50.014). Haemocytes
which had been pre-exposed to fumagillin and subse-
quently PMA-stimulated showed retention of 50.2±2.3%
of p47 in the cytosolic fraction compared with
37.4±1.09% of the protein in the cytosolic fraction of
PMA-stimulated haemocytes (P50.01).
Fumagillin-treated haemocytes demonstrate
reduced levels of degranulation
During phagocytosis and the generation of ROS,
neutrophils undergo the process of degranulation, and
one of the most abundant proteins released during
degranulation is MPO, which accounts for up to 5% of
the protein content of the cell (Klebanoff, 1999). Using an
anti-MPO antibody, the rate of haemocyte degranulation
was quantified. Cells were induced to degranulate by
exposure to PMA in a stirred thermostatically controlled
reaction chamber, and the presence of protein in the
secretome to which the anti-MPO antibody reacted was
quantified by Western blotting (Fig. 6). The results
revealed that the level of protein to which the anti-MPO
antibody reacted in fumagillin-treated haemocytes was
significantly lower than that in PMA-activated or in
solvent-treated PMA-activated haemocytes (P50 and
0.049, respectively). The anti-MPO antibody was observed
to react with two proteins, and these were approximately
59.5 kDa in size. Both proteins to which the anti-MPO
antibody reacted were excised and analysed by LC-MS as
described above. The results revealed the larger protein to
be a prophenoloxidase (PPO), an enzyme known to be
present in insect haemocytes (Mandato et al., 1997) and
released during degranulation (the excised protein Mascot
score was 501, 24% coverage, with 10 distinct peptide
matches to G. mellonella PPO, accession no. AF336289.1).
The second protein was also identified as PPO (Mascot
score 309, 13% coverage with five distinct peptide
matches).
DISCUSSION
The insect immune response demonstrates a number of
similarities to the innate immune response of mammals
and, as a consequence, insects have become an attractive
alternative to the use of mammals for assessing the
virulence of microbial pathogens (Brennan et al., 2002;
Fuchs & Mylonakis, 2006; Johny et al., 2007) or for
assessing the efficacy of novel antimicrobial drugs (Rowan
et al., 2009; Hamamoto et al., 2009; Lionakis et al., 2005).
Larvae of G. mellonella offer many advantages for this type
of work in that they are inexpensive to purchase and
inoculate, and have no ethical or legal impediments to their
use (Kavanagh & Reeves, 2004; Fuchs & Mylonakis, 2006;
Mylonakis, 2008). G. mellonella larvae have been used to
assess the virulence of A. fumigatus (Renwick et al., 2006;
Jackson et al., 2009), but little attention has been given to
understanding the interaction of this fungus with the insect
immune response. We previously demonstrated a correla-
tion between gliotoxin production and virulence of A.
fumigatus in G. mellonella larvae (Reeves et al., 2004), and
also demonstrated the ability of gliotoxin to block p47 and
p67 translocation and thus prevent the formation of a
functional NADPH oxidase complex in insect haemocytes
(Renwick et al., 2007).
Fumagillin is produced during the growth of A. fumigatus
(Mitchell et al., 1997) and may play a role in suppressing
the immune response of the host. The aim of this work was
to investigate the interaction of fumagillin with haemo-
cytes, which are the main component of the cellular
immune response of insects (Morton et al., 1987). Since
larvae of G. mellonella are a convenient and effective host
Fig. 4. Oxygen consumption of fumagillin-treated haemocytes.
Haemocytes (5107) were incubated in the presence of 2 mg
fumagillin ml”1 (Fum) and stimulated with 1 mg PMA ml”1. A
significant reduction in the consumption of oxygen was observed
compared with control cells (Solv Ctrl) (P50.003).
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for studying fungal virulence, understanding the inter-
action of A. fumigatus with the insect immune response
might give insights into how this fungus grows and
develops in insects and, by extrapolation, in mammals.
Inoculation of larvae with fumagillin had no adverse effect
on larval viability; however, administration of this toxin to
G. mellonella larvae rendered them more susceptible to
infection with conidia of A. fumigatus. In particular, those
larvae that received a dose of 2 mg fumagillin ml21 showed
a mortality rate of 80±5.7% at 72 h compared with
53.33±12.0% in larvae that were not pre-injected
(P50.0052). Fumagillin reduced the ability of haemocytes
to phagocytose opsonized A. fumigatus conidia and kill
opsonized C. albicans cells. The percentage inhibition in
phagocytosis was 14.71%, while the reduction in killing
(relative to the control) was 44.36%, which indicated that
as well as retarding phagocytosis fumagillin was also
affecting the killing mechanism of haemocytes.
Neutrophils are similar in structure and function to
haemocytes (Bergin et al., 2005), which mediate their
killing by the production of ROS and by releasing
degradative enzymes in the process of degranulation
(Spitznagel, 1990). During the process of degranulation a
wide range of enzymes are released into the phagosome and
around the periphery of the cell (Standish & Weiser, 2009).
The generation of ROS is a critical part of the haemocyte’s
ability to kill an engulfed cell (Bergin et al., 2005), and the
suppression of this would adversely affect its killing ability.
Exposure of haemocytes to fumagillin resulted in a
reduction in oxygen uptake without adversely affecting
Fig. 5. Presence of p47 protein in cytosolic
and membrane fractions of G. mellonella
haemocytes. Haemocytes (1108) were incu-
bated in the presence of 2 mg fumagillin ml”1
(Fum) and fractionated as described in
Methods. Following electrophoresis and immu-
noblotting, densitometric analysis was used to
quantify the relative abundance of p47 in the
cytosol and membrane fractions, and these
values are expressed in terms of the percent-
age distribution of p47 in the fractions.
Haemocytes which were pre-exposed to
fumagillin showed a significant reduction in
p47 translocation compared with controls [i.e.
PMA- and solvent and PMA-stimulated
(Solv+PMA) haemocytes] (P¡0.035). UT,
untreated.
Fig. 6. Visualization of anti-MPO reactivity in
the secretome of G. mellonella haemocytes.
Haemocytes were incubated in the presence
of 2 mg fumagillin ml”1 (Fum) and placed in a
stirred chamber maintained at 37 6C. Six
minutes post PMA stimulation, the contents
of the chamber were centrifuged at 800 g for
5 min to pellet cells and cellular debris. The
supernatant was subjected to electrophoresis
and immunoblotting with a mammalian anti-
MPO antibody. There was a significant reduc-
tion in MPO-like reactivity compared with the
PMA only and solvent and PMA (Solv+PMA)
controls (P¡0.049). UT, untreated.
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haemocyte viability. Reduced oxygen uptake indicates a
reduction in the generation of ROS, since this is dependent
upon a sufficient supply of oxygen and the presence of a
functional NADPH oxidase complex. Fumagillin-treated
cells demonstrated reduced release of PPO upon stimu-
lation with PMA.
Recent work has demonstrated that 2 mg fumagillin ml21
retards the ability of human neutrophils to phagocytose
and kill microbial cells, and this is also due to a reduction
in the formation of a functional NADPH oxidase complex
(Fallon et al., 2010). We demonstrated that fumagillin
adversely influences many of the structural rearrangements
(phagocytosis, formation of functional NADPH oxidase,
degranulation) essential for the formation of an activated
cell (Fallon et al., 2010). The current work demonstrates
that fumagillin induces similar effects in insect haemocytes,
thus demonstrating further similarities between the two
cell types. At the cellular level there is a high degree of
homology between the insect immune response and the
innate immune response of mammals (Salzet, 2001). Both
insect haemocytes and human neutrophils phagocytose
and kill pathogens by the generation of ROS, and this is
mediated by a similar NADPH oxidase complex in both
cell types (Bergin et al., 2005). In addition, both
neutrophils and haemocytes respond to gliotoxin
(Tsunawaki et al., 2004; Renwick et al., 2007) and
fumagillin (Fallon et al., 2010; this work) in a similar
manner. These results extend the number of similarities
between the two immune systems and highlight the
suitability of using insects as an alternative screening
system to mammals.
The use of insects for studying microbial pathogens and for
assessing the efficacy of novel antimicrobial drugs is
increasing (Peleg et al., 2009). This work has demonstrated
that fumagillin has the ability to suppress the immune
response of G. mellonella larvae by interfering with the
function of haemocytes. During growth of A. fumigatus in
the larvae, fumagillin, together with other toxins and
enzymes (Rementeria et al., 2005), may play a role in
suppressing the immune response, thus facilitating hyphal
growth. The utility of the insect system is widely recognized,
and this work, together with others, has highlighted a further
similarity (Salzet, 2001) between the insect immune
response and the innate immune response of mammals.
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